Marcia Silveira Graudenz
Overview
Explore the profile of Marcia Silveira Graudenz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruppenthal R, Pilar E, Santos J, Coelho R, Henriques C, Uchoa D, et al.
Womens Health (Lond)
. 2025 Jan;
21:17455057241304654.
PMID: 39745077
Background: Breast cancer (BC) is a significant burden on healthcare systems, especially in low- and middle-income countries where access to diagnosis and treatment is challenging. Objectives: The purpose of this...
2.
Santana V, Kruger V, Abrahao M, Cantu P, Brackmann R, Pandolfi G, et al.
Head Neck Pathol
. 2024 Mar;
18(1):14.
PMID: 38457034
Background: Despite the increasing recognition of PD-L1 as predictor of immunotherapeutic response in various malignancies, its role and prognostic significance in thyroid cancer remain underexplored and subject to debate. This...
3.
Walter L, Fernandes P, Strieder D, Scheinpflug A, Zanella A, Faccin C, et al.
Eur J Endocrinol
. 2023 Nov;
189(6):584-589.
PMID: 38033287
Objective: The influence of age on the malignant cytology rate of thyroid nodules remains uncertain. The American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) is currently...
4.
Walter L, Scheffel R, Zanella A, Farenzena M, Faccin C, Graudenz M, et al.
Thyroid
. 2023 Jan;
33(3):312-320.
PMID: 36680747
The most frequent site of recurrence of differentiated thyroid cancer (DTC) is cervical lymph nodes (LNs), which often necessitates repeated surgical interventions and morbidity in a generally indolent disease. Data...
5.
Goemann I, Marczyk V, Recamonde-Mendoza M, Wajner S, Graudenz M, Maia A
Sci Rep
. 2020 Aug;
10(1):13914.
PMID: 32807826
Thyroid hormones (THs) are critical regulators of cellular processes, while changes in their levels impact all the hallmarks of cancer. Disturbed expression of type 3 deiodinase (DIO3), the main TH-inactivating...
6.
Vargas C, Ceolin L, Scheffel R, Benini A, Graudenz M, Maia A
Endocrine
. 2020 Jun;
70(3):544-551.
PMID: 32535684
Purpose: Elevated serum levels of carbohydrate antigen 19.9 (CA19.9), a well-established tumor marker in pancreatic neoplasms, has been proposed as a prognostic marker of tumor aggressiveness in medullary thyroid carcinoma...
7.
Reinert T, Ramalho S, de Vasconcelos V, Silva L, da Silva A, de Andrade C, et al.
Front Oncol
. 2020 Apr;
10:342.
PMID: 32309212
Mutations in the gene (m) are important mechanisms of resistance to endocrine therapy in estrogen receptor-positive (ER+) metastatic breast cancer and have been studied as a potential therapeutic target, as...
8.
Nava C, Scheffel R, Cristo A, Ferreira C, Weber S, Zanella A, et al.
Front Endocrinol (Lausanne)
. 2019 Nov;
10:712.
PMID: 31695679
Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for...
9.
Reinert T, Coelho G, Mandelli J, Zimermann E, Zaffaroni F, Bines J, et al.
J Oncol
. 2019 Sep;
2019:1947215.
PMID: 31511774
Mutations in the gene () are important mechanisms of resistance to endocrine therapy in estrogen receptor-positive advanced breast cancer and have been recognized as a prognostic and predictive biomarker as...
10.
Reinert T, Nogueira-Rodrigues A, Kestelman F, Ashton-Prolla P, Graudenz M, Bines J
Clin Breast Cancer
. 2018 Apr;
18(4):e587-e594.
PMID: 29680194
This narrative literature review addresses the problem of an adnexal mass discovered during the course of breast cancer (BC) care, which may represent a benign condition, a metastatic process, or...